Chronic inflammatory bowel diseases (IBD), such as ... A key issue in treating IBD is the profound disruption of the metabolic interaction between the body and the microbiome—the community ...

Scores on a broad panel of blood metabolomic markers may predict inflammatory bowel disease (IBD) up to 10 years before onset, indicated a new study that leveraged population data from three ...

It’s caused by nutritional deficiencies. Metabolic bone disease refers to a group of diseases that weaken your bones. The most common ones are osteoporosis, osteopenia, and osteomalacia.

including 11 with ulcerative colitis and 26 with Crohn’s disease. Patients with any three of the following characteristics were considered to have metabolic syndrome (MetS): BMI greater than 30 ...

Not just because she's a well-educated, pediatric endocrinologist and metabolic bone disorder specialist at Phoenix Children’s Hospital. But because the 41-year-old physician has the disease ...

induces clinical remission in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD). Around 2% to 14% of IBD patients develop PSC, and in turn, most PSC patients develop ...

This observation was consistent with previous studies that documented an increased risk of metabolic syndrome and cardiovascular disease in IBD patients. The sub-group analysis indicated a higher ...

Meta-analysis of the five case-control studies showed that patients with psoriasis were 1.7 times more likely to develop Crohn disease and 1.75 times more likely to develop ulcerative colitis than ...

an oral investigational med that the biotech was assessing in a phase 2/3 IBD trial and touted as phase 2-ready in liver fibrosis. The asset also has potential applications in metabolic diseases ...

Western diets pose a greater risk of Inflammatory Bowel Disease (IBD) and colorectal cancer ... balance of microorganisms in our gut and their metabolic functions." The review offers valuable ...